4th Quarter - Amendment
BROWNSTEIN HYATT FARBER SCHRECK, LLP for NOVARTIS
Client
Income
$50,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 20, 2020 | $50,000 | Replaced |
| 4th Quarter - Amendment (this page) | Jul 8, 2020 | $50,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Tax filing programs
| Lobbyist | Covered position, as disclosed |
|---|---|
| RADHA MOHAN New | — |
Medical/Disease Research/Clinical Labs MED
Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMILY FELDER | — |
Health Issues HCR
Issues related to cell and gene therapy Pharmaceutical pricing Issues related to the development of therapies for rare diseases
| Lobbyist | Covered position, as disclosed |
|---|---|
| NADEAM ELSHAMI | — |
| MARC LAMPKIN | — |
| BRIAN MCKEON | — |
| JEROME MURRAY | — |
| ZACHARY PFISTER | — |
| BRIAN WILD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.